A carregar...
CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements
Warfarin continues to be the mainstay therapy for preventing thrombus formation. Although pharmacogenetic algorithms have shown higher predictability of the optimal warfarin dose and lower occurrence of bleeding episodes, they often do not include ethno-specific genetic variants relevant to non-Euro...
Na minha lista:
| Publicado no: | Pharmacogenomics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6479273/ https://ncbi.nlm.nih.gov/pubmed/30518301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2018-0143 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|